Cancer
Novartis recognised for efforts in cancer
August 8, 2013Medical Communications, Sales and Marketing Bush, CEO, Cancer, Novartis
Novartis is the first company to earn a global CEO Cancer Gold Standard accreditation by the non-profit organisation CEO Roundtable …
Late-stage failure for Afinitor
August 8, 2013Research and Development, Sales and Marketing Afinitor, Cancer, Novartis, liver
Novartis’ oncology programme has received a blow with the news that Afinitor has failed to help patients live longer in …
GSK loses Tyverb patent
August 6, 2013Sales and Marketing Cancer, GSK, GlaxoSmithKline, Tyverb
GlaxoSmithKline has received a knockback from authorities in India, who have revoked the patent on its breast cancer drug Tyverb. …
Roche breast cancer drug Perjeta rejected by NICE
August 6, 2013Sales and Marketing Cancer, NICE, Perjeta, Roche
NICE is not recommending Roche’s next generation breast cancer drug Perjeta as a treatment for a particular type of advanced …
EMA: no cancer risk from GLP-1s
July 29, 2013Research and Development, Sales and Marketing Cancer, EMA, GLP-1s
One of the European Medicines Agency’s key advisory groups has decided that concerns over an increased cancer risk with some …
Boehringer nears European approval for first cancer drug
July 29, 2013Sales and Marketing Boehringer, Cancer, FDA, afatinib
Boehringer’s first cancer drug is just months away from being approved in Europe after a committee for the EMA gave …
Merck Serono sets up cancer platform
July 3, 2013Research and Development, Sales and Marketing Cancer, Cladribine, Merck Serono, kgaa
Merck Serono is attempting to speed up R&D on products which stimulate the immune system to fight cancer by establishing …
Sanofi makes Curie cancer deal
June 20, 2013Research and Development, Sales and Marketing Cancer, R&D, Sanofi, curie
Sanofi has signed a three-year research collaboration with the Curie Institute to identify new therapeutic targets which will help develop …
UK gene scientist honoured with knighthood
June 17, 2013Medical Communications, Research and Development, Sales and Marketing Cancer, genes, knighthood, mike stratton, personalised
A British scientist who helped discover the BRCA breast cancer gene and paved the way for personalised medicine has been …
‘Game-changing’ cancer database launched
June 13, 2013Medical Communications, Research and Development, Sales and Marketing Cancer, Department of Health, NHS
The Department of Health has unveiled a new system for co-ordinating cancer treatment which it hopes will save thousands of …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
